🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

IgGM: A Generative Model for Functional Antibody and Nanobody Design 1/ IgGM is a novel generative model designed to facilitate the de novo design of antibodies and nanobodies with functional specificity, focusing on their ability to bind specific antigens. This model uniquely

Using physics to escape the pit [📹 sports.tjchina]

Botticelli, 1481

Leonardo da Vinci, 1506

Excited for the upcoming Australian Amyloidosis Network #Amyloidosis2025 workshops and dinner meetings with international speakers A/Prof Carol Whelan , Prof Efstathios Kastritis and Prof Yoshiki Sekijima Registration and program: aanworkshops.org.au

Cherry blossoms in Japan 🧵 1. A tunnel of sakura-shaped bulbs in Mie

Happy CD3 CD28 T Cell Stimulation Day to all who celebrate #TCell #immunology

The Birth of Venus is a painting of beauty, grace, and myth. But behind it was a bold act of defiance — Botticelli painted pagan gods in a Christian city ruled by fear. It nearly got him erased from history for 300 years. Here’s the story no one tells. 🧵

Sunday by Seurat

The pro-inflammatory cytokine IL6 suppresses mitochondrial function via the gp130-JAK1/STAT1/3-HIF1α/ERRα axis sciencedirect.com/science/articl…

Our work has just been published in Cancer Research! We found that ammonia produced by cancer cells in the TME suppresses NK and T cells, which may reduce the efficacy of immunotherapies, including CAR-NK and CAR-T cell therapies Cancer Research AACR aacrjournals.org/cancerres/arti…

🚨BREAKING: Stanford University just launched a FREE AI tool for researchers! It writes Wikipedia-quality reports with 99% accuracy & citations. Here’s how to access it for free:

Review Article: Neonatal Fc Receptor — Biology and Therapeutics nej.md/42gEZYk #Gastroenterology #OBGYN

Identification of Hepatic-like EPO as a Cause of Polycythemia | New England Journal of Medicine nejm.org/doi/full/10.10…

🧬 The Next Decade of In-Vivo CAR-T (2025–2035) We’re entering a new era where cell therapies are made inside the body. No apheresis. No chemo. Just a shot or a drip, and your T cells get reprogrammed on site. Here’s the clearest roadmap for the next 10 years 👇🏼

The first of Australia’s Amyloidosis 2025 Workshop and Conference series have kicked off in Perth Western Australia today. 2 of our International experts Carol Whelan and Prof Efstathios Kastritis seen here with Perth’s AAN clinic director Hasib Sidiqi Smiles all round.

Melbourne in May on Amyloidosis Day! Great workshop with Stathis The Australian Amyloidosis Network patients’ association is now led by Maureen & Garry Mahon (took over from the great Pat Neely). Loved catching up with Brendan, Olga and James. Thank you.

Updates in AL amyloidosis by Stathis at Australian Amyloidosis Network #Amyloidosis2025

Common Terminology Criteria for Adverse Events (CTCAE) has 26 categories for 837 terms, and 3,185 options when you account for Grade 1 to 5 🤯! I wanted to be able to interactively visualize CTCAE so I some wrote code 🧑‍💻 TheCodingDocs.com Take a look at --> thecodingdocs.com/clincal/ctcae